Search
SOLACI Congress
HomeFile

File

View Category
Structural heart disease

Tricuspid Edge-to-Edge Repair: One-Year Evolution

Tricuspid Edge-to-Edge Repair has emerged as a promising alternative to surgical repair. Different studies have shown it...
Dr. Carlos Fava -
Learn More
Structural heart disease

DIRECT TAVI: Is Predilation Important for Women?

Predilation was used in the early stages of TAVR to facilitate device advancing. However, the increasing operator...
Dr. Carlos Fava -
Learn More
Chronic Coronary Syndromes

EMPIRE Trial: Is Microvascular Protection Feasible in PCI Depending on the Stenting Technique?

Percutaneous coronary intervention (PCI) may entail inherent complications, such as a diagnosis of periprocedural myocardial infarction (MI...
solaci -
Learn More
Bifurcations

Stent Optimal Minimal Area and Stent Underexpansion Impact in 2-Stent Left Main Treatment

The upfront 2-stent strategy for left main bifurcation treatment presents a technical challenge and has been associated...
Dr. Andrés Rodríguez -
Learn More
Structural heart disease

Severe Aortic Stenosis in Bicuspids: Promising Self-Expanding Valve Outcomes at 3 years

Bicuspid aortic valves represent a significant challenge in TAVR because of its anatomical complexity and the presence...
Dr. Carlos Fava -
Learn More
Other

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known...
solaci -
Learn More
Peripheral vascular disease

Selecting Renal Denervation Responsive Patients: Meta-Analysis of Observational Data

Hypertension treatment has evolved considerably over time. However, managing adverse events driven by medication is still challenging,...
solaci -
Learn More
Structural heart disease

Myocardial Damage in MAC

Mitral annulus calcification (MAC) affects between 8% and 23% of the population. It is more common in...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

Dr. Omar Tupayachi - 0
The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Dr. Andrés Rodríguez - 0
Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Dr. Juan Manuel Pérez - 0
Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy